A manuscript written by NuOrtho's Chief Clinical Officer has been accepted for publication in the nanotechnology scientific journal, International Journal of Nanosystems. The manuscript highlights the design of NuOrtho's flagship arthroscopic surgical device, Ceruleau, a physiochemical scalpel, which gives surgeons an advanced option for treating damaged articular cartilage. Ceruleau has been developed in order to decrease the disease burden of osteoarthritis.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
Amedica Names Jay Moyes to Board of Directors
Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%